Target intelligence / Profile preview

Protein cysteine CoAlation (CoAlation) (CoAlation)

Target
CoAlation
Molecular classification
Post-translational modification, Redox modification, Other
01

Overview

Protein CoAlation is a reversible post-translational modification (PTM) where Coenzyme A (CoA) forms a covalent disulfide bond with specific cysteine residues on proteins, primarily during oxidative or metabolic stress (Gout, 2018, Biochemical Society Transactions). This modification serves a dual purpose: it protects critical protein thiols from irreversible over-oxidation to sulfinic or sulfonic acids and regulates the activity of various metabolic and signaling proteins (Tsuchiya et al., 2017, Biochemical Journal). The process is highly dynamic and is reversed by de-CoAlating enzymes, such as Nudix hydrolases (e.g., NUDT7 and NUDT15), which cleave the CoA-protein bond (Baković et al., 2019, Free Radical Biology and Medicine). Research has identified a wide range of CoAlated proteins, termed the "CoAlome," which includes key enzymes in glycolysis, the TCA cycle, and antioxidant defense, effectively linking cellular metabolism with redox status (Malanchuk et al., 2021, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy). While no clinical drugs currently target this process directly, the modulation of de-CoAlating enzymes or cellular CoA levels represents a promising therapeutic strategy for diseases associated with oxidative stress, such as cancer, neurodegeneration, and ischemia-reperfusion injury.

Other names
S-CoAlationProtein S-CoAlationCoenzyme A-lationCovalent CoA-protein adducts
02

Mechanism of action

Reversible covalent modification of cysteine thiols by Coenzyme A to protect against irreversible oxidation and regulate enzymatic activity.

03

Biological functions

Redox regulationMetabolic regulationProtection of protein thiolsSignal transductionCellular stress response
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseIschemia-reperfusion injuryInfection
05

Safety considerations

Potential for systemic metabolic disruption due to the central role of Coenzyme A in the TCA cycle and fatty acid metabolismOff-target effects on essential redox-sensitive signaling pathways
06

Interacting drugs

NUDT7 inhibitors (experimental)

2 more in the full profile.

07

Biomarkers

Anti-CoA monoclonal antibodies (e.g., clone 1F10)CoA-modified protein levels (Mass spectrometry profiling)

Beyond the preview

Go deeper on Protein cysteine CoAlation (CoAlation) (CoAlation).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein cysteine CoAlation (CoAlation) (CoAlation).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call